← Back to Clinical Trials
Recruiting NCT06477887

NCT06477887 Post Extraction Changes Following Ridge Preservation Using Allogenis Dentin Vs Autogenous Partially Demineralized Dentin

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06477887
Status Recruiting
Phase
Sponsor Cairo University
Condition Socket Preservation
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2024-06-03
Primary Completion 2024-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Allogeneic Dentin MatrixAutogenous Partially Demineralized Dentine Matrix

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2024-06-03 with a primary completion date of 2024-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Research question: In patients with unrestorable anterior teeth, will the use of allogenic dentin matrix be more effective than autogenous partially demineralized dentine matrix (APDDM) in reducing hard tissue changes after post-extraction ridge preservation in the aesthetic zone? After enrolment, periodontal and radiographic examinations will be conducted, and patients with badly unrestorable teeth in the aesthetic zone will be identified. These patients will undergo measurements of mesio-distal distance between adjacent teeth, corono-apical height of bone, the presence of a labial undercut, dehiscence, or fenestration, and the relationship to adjacent teeth using the transgival probing technique and a preapical radiograph, or CBCT. In both groups, the desired tooth will be atraumatically extracted under local anaesthesia using peritomies and surgical forceps. In the intervention group: preparation of the allogenic dentin matrix. Steps of Allogenic Dentin Processing: Washing with distilled water for 30-120 minutes Ultrasonic cleaning cycles: 1st with distilled water for 5-10 minutes, 2nd with 5-7% hydrogen peroxide 10-30 minutes, then 3 minutes with distilled water for 5-10 minutes at 60-80 Defatting with Chloroform Methanol Solution 1:0.5 for 3-12 hours. Demineralization with 0.5% HCL for 10-60 min Dehydration with Neutral Ethyl Alcohol for 30 minutes, then defatting with Chloroform Methanol Solution 1:0.5 for 3-12 hours Washing with normal saline and freeze-drying, then sterilisation using ethylene oxide gas. After the recovery period of 6 months", a biopsy is taken for cases from the site of the operation for histological evaluation during implant placement. • In the control group, the teeth will be cleaned and dried, and then the dentin will be ground to obtain particles of a certain size, which will be partially demineralized by using a tooth transformer machine. In both groups, the dentin graft will be placed inside the socket, and then a 5/0 proline suture will be used to fix the collagen membranes to cover the graft. After the recovery period of 6 months", a biopsy is taken for cases from the site of the operation for histological evaluation during implant placement. Outcome: Radiographic bucco-lingual ridge width loss. Radiographic palatal vertical bone changes. Radiographic buccal vertical bone changes. Percentage of new vital bone formation. Percentage of residual bone graft. Implant Primary Stability.

Eligibility Criteria

Inclusion Criteria: * Patients with good health status (ASA-1, ASA-2). * Adult patients over 18 years old. * Patients with non-restorable teeth in the aesthetic zone for periodontal, carious, or traumatic reasons. * Extraction socket with no more than 50% buccal bone loss. * Patients accept a 6-month follow-up period (cooperative patients). * Patients provide informed consent. Exclusion Criteria: * Patients reporting systemic conditions that may compromise healing (e.g., uncontrolled diabetes). * Patients with poor maintenance of oral hygiene. * Pregnancy. * Smokers. * Patients taking any medications that could compromise healing.

Contact & Investigator

Central Contact

Abdullah Matar

✉ dr.@bood@gmail.com

📞 01203333038

Frequently Asked Questions

Who can join the NCT06477887 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Socket Preservation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06477887 currently recruiting?

Yes, NCT06477887 is actively recruiting participants. Contact the research team at dr.@bood@gmail.com for enrollment information.

Where is the NCT06477887 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06477887 clinical trial?

NCT06477887 is sponsored by Cairo University. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology